
Roza 12.5mg Tablet ER
Marketer
Events Pharma
Salt Composition
Zolpidem (12.5mg)
Overview Roza 12.5mg Tablet ER
Somnia 12.5mg Extended-Release Tablets are indicated for the short-term management of sleep disturbances. They shorten sleep latency and reduce nocturnal awakenings, promoting consolidated sleep. Somnia 12.5mg ER should be administered on an empty stomach, ideally just before bedtime, at the same time daily for consistent blood levels. Adhere strictly to your physician's prescribed dosage and duration, as this medication can be habit-forming; abrupt cessation should be discussed with your doctor to avoid symptom exacerbation. Potential side effects include, but are not limited to: cognitive impairment, visual disturbances, restlessness, cephalalgia, dizziness, gastrointestinal upset (nausea, vomiting, diarrhea), myalgia, and fatigue; depression may also occur. Most side effects are transient. Report persistent or bothersome effects to your doctor immediately. Due to the sedative effects of Somnia 12.5mg ER, avoid driving or activities requiring alertness until its impact is known. Alcohol consumption should be avoided. Report any unusual mood changes, new or worsening depression, perceptual distortions, or suicidal ideation to your healthcare provider. Disclose all current medications to your physician prior to initiating Somnia 12.5mg ER therapy. Pre-existing hepatic or renal impairment necessitates prior consultation. Smoking and alcohol should be avoided during treatment. This medication is contraindicated during pregnancy and lactation; consult your physician if use is necessary.
Primary Ingredients of Roza 12.5mg Tablet ER
There is no text provided to rephrase.
Uses of Roza 12.5mg Tablet ER
Managing Sleep Difficulties
Major Benefits of Roza 12.5mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Roza 12.5mg Extended-Release Tablet on an empty stomach.
Common Side effects of Roza 12.5mg Tablet ER:
- Dizziness
- Sleepiness
- Headache
- Nausea
- Stomach pain
- Memory loss
- Vertigo
- Vomiting
- Back pain
- Agitation
- Double vision
- Depression
How to use Roza 12.5mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Roza 12.5mg Extended-Release Tablets. Swallow the tablet whole; do not chew, crush, or break it. Administer on an empty stomach.
How Roza 12.5mg Tablet ER works:
Roza 12.5mg Extended-Release Tablets are classified as non-benzodiazepine sleeping aids. This medication possesses hypnotic, sedative, and anticonvulsive effects, controlling seizures. Its mechanism involves interaction with the GABAA receptor chloride channel complex, a neurotransmitter receptor, reducing neuronal activity in the brain to promote sleep onset.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Roza 12.5mg extended-release tablets and alcohol can lead to significant somnolence.
PregnancyCONSULT YOUR DOCTOR
Extended-release Roza 12.5mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Roza 12.5mg tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Extended-release Roza 12.5mg tablets can cause drowsiness, blurred vision, and dizziness. Driving is inadvisable if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Roza 12.5mg tablets are considered safe for use by individuals with kidney impairment; dosage modification is not typically necessary. Nevertheless, disclosure of any kidney condition to your physician is advised.
LiverCAUTION
Individuals with liver impairment should use Roza 12.5mg Extended-Release tablets cautiously. Dosage modification of Roza 12.5mg Extended-Release tablets may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, Roza 12.5mg Extended-Release tablets are typically initiated at a reduced dosage; however, it's contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Roza 12.5mg Tablet ER :
Omit any missed Roza 12.5mg Extended-Release Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Roza 12.5mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Imidazopyridine compound |
| Developing Habits | Affirmative. |
| Treatment Category | Neuroscience (Central Nervous System) |
| Action Class | Non-benzodiazepine sleeping pills (Z-drugs) |
